Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-25,572
Closed -$1.02M 1760
2026
Q1
$1.02M Buy
+25,572
New +$1.21M 0.04% 389
2025
Q3
Sell
-9,899
Closed -$476K 1641
2025
Q2
$476K Sell
9,899
-1,729
-15% -$75.2K 0.02% 678
2025
Q1
$467K Sell
11,628
-6,308
-35% -$265K 0.02% 726
2024
Q4
$821K Sell
17,936
-35,231
-66% -$1.58M 0.04% 418
2024
Q3
$2.49M Buy
+53,167
New +$2.42M 0.01% 1407

Other funds holding QGEN

GTS Securities's QGEN Position: Q2 2026 in Review

GTS Securities sold out of Qiagen (QGEN) in Q2 2026, closing a stake of 25,572 shares — an estimated $1.02M sold.

GTS Securities first reported a position in QGEN in Q3 2024 and held it in 5 quarters. The position peaked at $2.49M in Q3 2024. 337 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

  • GTS Securities reported no remaining Qiagen position as of Q2 2026 after selling out during the quarter.
  • GTS Securities sold 25,572 Qiagen shares in Q2 2026, an estimated $1.02M.
  • GTS Securities first reported a position in Qiagen in Q3 2024 and held it in 5 quarters.
  • GTS Securities's Qiagen position peaked at $2.49M in Q3 2024.
  • 337 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on GTS Securities's 13F filing for Q2 2026, filed 14 Aug 2026.